BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 31792737)

  • 21. [Melatonin in complex treatment for colorectal cancer patients].
    Pliss MM
    Vopr Onkol; 2016; 62(3):413-7. PubMed ID: 30462903
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Potential use of melatonin in skin cancer treatment: A review of current biological evidence.
    Pourhanifeh MH; Mahdavinia M; Reiter RJ; Asemi Z
    J Cell Physiol; 2019 Aug; 234(8):12142-12148. PubMed ID: 30618091
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Therapeutic potential of melatonin in colorectal cancer: Focus on lipid metabolism and gut microbiota.
    Pan S; Guo Y; Hong F; Xu P; Zhai Y
    Biochim Biophys Acta Mol Basis Dis; 2022 Jan; 1868(1):166281. PubMed ID: 34610472
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Melatonin: from basic research to cancer treatment clinics.
    Vijayalaxmi ; Thomas CR; Reiter RJ; Herman TS
    J Clin Oncol; 2002 May; 20(10):2575-601. PubMed ID: 12011138
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Melatonin and breast cancer: cellular mechanisms, clinical studies and future perspectives.
    Grant SG; Melan MA; Latimer JJ; Witt-Enderby PA
    Expert Rev Mol Med; 2009 Feb; 11():e5. PubMed ID: 19193248
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-Angiogenics: Their Value in Colorectal Cancer Therapy.
    Seeber A; Gunsilius E; Gastl G; Pircher A
    Oncol Res Treat; 2018; 41(4):188-193. PubMed ID: 29562227
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antiangiogenic Therapy in Colorectal Cancer.
    Mody K; Baldeo C; Bekaii-Saab T
    Cancer J; 2018; 24(4):165-170. PubMed ID: 30119079
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vivo effects of chemotherapy on oncogenic pathways in colorectal cancer.
    Spartalis C; Schmidt EM; Elmasry M; Schulz GB; Kirchner T; Horst D
    Cancer Sci; 2019 Aug; 110(8):2529-2539. PubMed ID: 31119819
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Melatonin and cancer: From the promotion of genomic stability to use in cancer treatment.
    Farhood B; Goradel NH; Mortezaee K; Khanlarkhani N; Najafi M; Sahebkar A
    J Cell Physiol; 2019 May; 234(5):5613-5627. PubMed ID: 30238978
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Melatonin, a Full Service Anti-Cancer Agent: Inhibition of Initiation, Progression and Metastasis.
    Reiter RJ; Rosales-Corral SA; Tan DX; Acuna-Castroviejo D; Qin L; Yang SF; Xu K
    Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28420185
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Role of Cyclooxygenase-2 in Colorectal Cancer.
    Sheng J; Sun H; Yu FB; Li B; Zhang Y; Zhu YT
    Int J Med Sci; 2020; 17(8):1095-1101. PubMed ID: 32410839
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Melatonin, immune function and cancer.
    Srinivasan V; Pandi-Perumal SR; Brzezinski A; Bhatnagar KP; Cardinali DP
    Recent Pat Endocr Metab Immune Drug Discov; 2011 May; 5(2):109-23. PubMed ID: 22074586
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Unveiling the Protective Role of Melatonin in Osteosarcoma: Current Knowledge and Limitations.
    Al-Ansari N; Samuel SM; Büsselberg D
    Biomolecules; 2024 Jan; 14(2):. PubMed ID: 38397382
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Melatonin as antioxidant, geroprotector and anticarcinogen.
    Anisimov VN; Popovich IG; Zabezhinski MA; Anisimov SV; Vesnushkin GM; Vinogradova IA
    Biochim Biophys Acta; 2006; 1757(5-6):573-89. PubMed ID: 16678784
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The potential utility of melatonin in the treatment of childhood cancer.
    Chao YH; Wu KH; Yeh CM; Su SC; Reiter RJ; Yang SF
    J Cell Physiol; 2019 Nov; 234(11):19158-19166. PubMed ID: 30945299
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The efficacy and safety of melatonin in concurrent chemotherapy or radiotherapy for solid tumors: a meta-analysis of randomized controlled trials.
    Wang YM; Jin BZ; Ai F; Duan CH; Lu YZ; Dong TF; Fu QL
    Cancer Chemother Pharmacol; 2012 May; 69(5):1213-20. PubMed ID: 22271210
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modulation of the immune system by melatonin; implications for cancer therapy.
    Moslehi M; Moazamiyanfar R; Dakkali MS; Rezaei S; Rastegar-Pouyani N; Jafarzadeh E; Mouludi K; Khodamoradi E; Taeb S; Najafi M
    Int Immunopharmacol; 2022 Jul; 108():108890. PubMed ID: 35623297
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Melatonin-mediated regulation of autophagy: Making sense of double-edged sword in cancer.
    Mirza-Aghazadeh-Attari M; Mohammadzadeh A; Adib A; Darband SG; Sadighparvar S; Mihanfar A; Majidinia M; Yousefi B
    J Cell Physiol; 2019 Aug; 234(10):17011-17022. PubMed ID: 30859580
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Standard chemotherapy with cetuximab for treatment of colorectal cancer.
    Li XX; Liang L; Huang LY; Cai SJ
    World J Gastroenterol; 2015 Jun; 21(22):7022-35. PubMed ID: 26078581
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Melatonin increases the anticancer potential of doxorubicin in Caco-2 colorectal cancer cells.
    Jadid MFS; Aghaei E; Taheri E; Seyyedsani N; Chavoshi R; Abbasi S; Khorrami A; Goleij P; Hajazimian S; Taefehshokr S; Isazadeh A; Shanehbandi D
    Environ Toxicol; 2021 Jun; 36(6):1061-1069. PubMed ID: 33507000
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.